Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Role of glucagon-like peptide-2 in intestinal carcinogenesis of rodent models of cancer.
EF 2009-10
Résumé
Glucagon-like peptide-2 (GLP-2) is a gut hormone that is secreted when a meal is eaten. In addition, GLP-2 regulates the growth and maintenance of cells that line the gastrointestinal tract. GLP-2 is needed for normal food digestion and absorption and also for intestinal growth. It is because of these actions that GLP-2 is currently in clinical trials for the treatment of Short Bowel Syndrome (SBS) and Crohn's disease. These digestive maladies are a growing concern for the Canadian population as well as a burden to the Canadian economy as they greatly decrease quality of life. However, since GLP-2 has growth effects in the gut, it is also necessary to examine whether it can cause colon cancer. This project, which is composed of two parts, will examine whether GLP-2 affects colon cancer in rats that have been fed with a carcinogen found in our diet. In addition, we will also examine whether GLP-2 increases colon cancer in mice with colitis. These studies will further our understanding about the role of GLP-2 in cancer, and could be relevant to patients being treated with GLP-2 and other patients who are at risk of colon cancer.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
201018
Name
Trivedi Shivangi
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Role of glucagon-like peptide-2 in intestinal carcinogenesis of rodent models of cancer.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Diet; Immunohistochemistry; In Vivo; Inflammatory Bowel Disease; Intestinal Hormones
Abstract
Glucagon-like peptide-2 (GLP-2) is a gut hormone that is secreted when a meal is eaten. In addition, GLP-2 regulates the growth and maintenance of cells that line the gastrointestinal tract. GLP-2 is needed for normal food digestion and absorption and also for intestinal growth. It is because of these actions that GLP-2 is currently in clinical trials for the treatment of Short Bowel Syndrome (SBS) and Crohn's disease. These digestive maladies are a growing concern for the Canadian population as well as a burden to the Canadian economy as they greatly decrease quality of life. However, since GLP-2 has growth effects in the gut, it is also necessary to examine whether it can cause colon cancer. This project, which is composed of two parts, will examine whether GLP-2 affects colon cancer in rats that have been fed with a carcinogen found in our diet. In addition, we will also examine whether GLP-2 increases colon cancer in mice with colitis. These studies will further our understanding about the role of GLP-2 in cancer, and could be relevant to patients being treated with GLP-2 and other patients who are at risk of colon cancer.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Trivedi, Shivangi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~